These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 20944661)

  • 1. Diabetic heart disease: the story continues.
    Shang Q; Yip GW
    J Hum Hypertens; 2011 Mar; 25(3):141-3. PubMed ID: 20944661
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diabetes, obesity and heart complications].
    Picard F; dos Santos P; Catargi B
    Rev Prat; 2013 Jun; 63(6):759-64. PubMed ID: 23923748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [ESC guidelines on diabetes, pre-diabetes and diseases of the cardiovascular system developed in cooperation with the EASD].
    ; Rydén L; Grant PJ; Anker SD; Berne C; Cosentino F; Danchin N; Deaton C; Escaned J; Hammes HP; Huikuri H; Marre M; Marx N; Mellbin L; Ostergren J; Patrono C; Seferovic P; Sousa Uva M; Taskinen MR; Tendera M; Tuomilehto J; Valensi P; Zamorano JL;
    Kardiol Pol; 2013; 71 Suppl 11():S319-94. PubMed ID: 24297732
    [No Abstract]   [Full Text] [Related]  

  • 4. [Obesity related complications in children and adolescents].
    Fichna P; Skowrońska B
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):223-8. PubMed ID: 17020660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteinuria in diabetes: bystander or pathway to cardiorenal disease?
    Karalliedde J; Viberti G
    J Am Soc Nephrol; 2010 Dec; 21(12):2020-7. PubMed ID: 21051738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comorbidities and microvascular complications of type 2 diabetes in children and adolescents.
    Dean HJ; Sellers EA
    Pediatr Diabetes; 2007 Dec; 8 Suppl 9():35-41. PubMed ID: 17991131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Iatrogenic hypoglycemia and cardiovascular risk in type 2 diabetes].
    Consoli A; Di Fulvio P
    G Ital Cardiol (Rome); 2012 Dec; 13(12):787-92. PubMed ID: 23196681
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential expression pattern of cardiovascular microRNAs in the human type-2 diabetic heart with normal ejection fraction.
    Rawal S; Ram TP; Coffey S; Williams MJ; Saxena P; Bunton RW; Galvin IF; Katare R
    Int J Cardiol; 2016 Jan; 202():40-3. PubMed ID: 26386917
    [No Abstract]   [Full Text] [Related]  

  • 9. The limited clinical value of a specific diabetic cardiomyopathy.
    Vigili de Kreutzenberg S; Avogaro A
    Nutr Metab Cardiovasc Dis; 2013 Jul; 23(7):599-605. PubMed ID: 23725770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Renal histological lesions in patients with type II diabetes mellitus].
    Castellano I; Covarsí A; Novillo R; Gómez-Martino JR; Ferrando L
    Nefrologia; 2002; 22(2):162-9. PubMed ID: 12085417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of diabetic cardiomyopathy in asymptomatic patients with type 2 diabetes.
    Seferović Mitrović JP; Seferović PM; Vujisić Tešić B; Petrović M; Ristić AD; Lalić K; Jotić A; Tešić M; Giga V; Milić N; Singh S; Lalić NM
    Int J Cardiol; 2012 Apr; 156(2):219-21. PubMed ID: 22336253
    [No Abstract]   [Full Text] [Related]  

  • 12. Diabesity: the combined burden of obesity and diabetes on heart disease and the role of imaging.
    Ng ACT; Delgado V; Borlaug BA; Bax JJ
    Nat Rev Cardiol; 2021 Apr; 18(4):291-304. PubMed ID: 33188304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A long story: from suspicion to identification of non-diabetic renal diseases in patients with diabetic mellitus.
    Liu G; Wang HY
    Nephrology (Carlton); 2006 Dec; 11(6):531-2. PubMed ID: 17199792
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevalence of complications and comorbidities in type 2 diabetes: a cross-sectional study of disease management program participants in Bavaria].
    Görlitz N; Keller M; Ziegler AG
    Dtsch Med Wochenschr; 2008 Aug; 133(33):1667-72. PubMed ID: 18686207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arterial hypertension and diabetes mellitus. Epidemiological and physiopathological aspects].
    Marengo C; Macchia G; Renzetti A; Fergonzi E; Pagano G
    Minerva Endocrinol; 1987; 12(4):257-72. PubMed ID: 3320726
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of cardiac lipotoxicity in the pathogenesis of diabetic cardiomyopathy.
    Ussher JR
    Expert Rev Cardiovasc Ther; 2014 Mar; 12(3):345-58. PubMed ID: 24552544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiologic and clinical features of patients with type 2 diabetes mellitus in primary care facilities (Sousse, Tunisie)].
    Ben Abdelaziz A; Drissi L; Tlili H; Gaha K; Soltane I; Amrani R; Ghannemr H
    Tunis Med; 2006 Jul; 84(7):415-22. PubMed ID: 17039732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal complications correlate with electrical atrial vulnerability hallmarks in type 2 diabetic patients.
    Montaigne D; Bailloeuil O; Hulin-Delmotte C; Edme JL; Sosner P; Miot A; Ragot S; Saulnier PJ; Dupuy O; Gourdy P; Lecomte P; Guerci B; Dardari D; Roussel R; Neviere R; Lacroix D; Hadjadj S;
    Int J Cardiol; 2012 Aug; 159(1):63-6. PubMed ID: 22713678
    [No Abstract]   [Full Text] [Related]  

  • 19. [Sex- and age-specific characteristics of arterial hypertension prevalence in type 2 diabetes mellitus patients with obesity].
    Kazymov MS; Fishman BB; Veber VR; Fishman MB; Kopina MN; Kuprin PE
    Ter Arkh; 2009; 81(4):73-5. PubMed ID: 19514427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart Failure and Diabetes Mellitus: Defining the Problem and Exploring the Interrelationship.
    Wilkinson MJ; Zadourian A; Taub PR
    Am J Cardiol; 2019 Dec; 124 Suppl 1():S3-S11. PubMed ID: 31741438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.